308 related articles for article (PubMed ID: 22158122)
1. Cysteine methylation disrupts ubiquitin-chain sensing in NF-κB activation.
Zhang L; Ding X; Cui J; Xu H; Chen J; Gong YN; Hu L; Zhou Y; Ge J; Lu Q; Liu L; Chen S; Shao F
Nature; 2011 Dec; 481(7380):204-8. PubMed ID: 22158122
[TBL] [Abstract][Full Text] [Related]
2. Identification of a Distinct Substrate-binding Domain in the Bacterial Cysteine Methyltransferase Effectors NleE and OspZ.
Zhang Y; Mühlen S; Oates CV; Pearson JS; Hartland EL
J Biol Chem; 2016 Sep; 291(38):20149-62. PubMed ID: 27445336
[TBL] [Abstract][Full Text] [Related]
3. Structure and specificity of the bacterial cysteine methyltransferase effector NleE suggests a novel substrate in human DNA repair pathway.
Yao Q; Zhang L; Wan X; Chen J; Hu L; Ding X; Li L; Karar J; Peng H; Chen S; Huang N; Rauscher FJ; Shao F
PLoS Pathog; 2014 Nov; 10(11):e1004522. PubMed ID: 25412445
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for specific recognition of Lys 63-linked polyubiquitin chains by NZF domains of TAB2 and TAB3.
Sato Y; Yoshikawa A; Yamashita M; Yamagata A; Fukai S
EMBO J; 2009 Dec; 28(24):3903-9. PubMed ID: 19927120
[TBL] [Abstract][Full Text] [Related]
5. RBCK1 negatively regulates tumor necrosis factor- and interleukin-1-triggered NF-kappaB activation by targeting TAB2/3 for degradation.
Tian Y; Zhang Y; Zhong B; Wang YY; Diao FC; Wang RP; Zhang M; Chen DY; Zhai ZH; Shu HB
J Biol Chem; 2007 Jun; 282(23):16776-82. PubMed ID: 17449468
[TBL] [Abstract][Full Text] [Related]
6. TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains.
Kanayama A; Seth RB; Sun L; Ea CK; Hong M; Shaito A; Chiu YH; Deng L; Chen ZJ
Mol Cell; 2004 Aug; 15(4):535-48. PubMed ID: 15327770
[TBL] [Abstract][Full Text] [Related]
7. Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains.
Li S; Zhang L; Yao Q; Li L; Dong N; Rong J; Gao W; Ding X; Sun L; Chen X; Chen S; Shao F
Nature; 2013 Sep; 501(7466):242-6. PubMed ID: 23955153
[TBL] [Abstract][Full Text] [Related]
8. The type III secretion effector NleE inhibits NF-kappaB activation.
Nadler C; Baruch K; Kobi S; Mills E; Haviv G; Farago M; Alkalay I; Bartfeld S; Meyer TF; Ben-Neriah Y; Rosenshine I
PLoS Pathog; 2010 Jan; 6(1):e1000743. PubMed ID: 20126447
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 and TRAF6-dependent activation of TAK1 in the absence of TAB2 and TAB3.
Zhang J; Macartney T; Peggie M; Cohen P
Biochem J; 2017 Jun; 474(13):2235-2248. PubMed ID: 28507161
[TBL] [Abstract][Full Text] [Related]
10. NleC, a type III secretion protease, compromises NF-κB activation by targeting p65/RelA.
Yen H; Ooka T; Iguchi A; Hayashi T; Sugimoto N; Tobe T
PLoS Pathog; 2010 Dec; 6(12):e1001231. PubMed ID: 21187904
[TBL] [Abstract][Full Text] [Related]
11. TAB2, TRAF6 and TAK1 are involved in NF-kappaB activation induced by the TNF-receptor, Edar and its adaptator Edaradd.
Morlon A; Munnich A; Smahi A
Hum Mol Genet; 2005 Dec; 14(23):3751-7. PubMed ID: 16251197
[TBL] [Abstract][Full Text] [Related]
12. The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65.
Newton HJ; Pearson JS; Badea L; Kelly M; Lucas M; Holloway G; Wagstaff KM; Dunstone MA; Sloan J; Whisstock JC; Kaper JB; Robins-Browne RM; Jans DA; Frankel G; Phillips AD; Coulson BS; Hartland EL
PLoS Pathog; 2010 May; 6(5):e1000898. PubMed ID: 20485572
[TBL] [Abstract][Full Text] [Related]
13. Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling.
Ishitani T; Takaesu G; Ninomiya-Tsuji J; Shibuya H; Gaynor RB; Matsumoto K
EMBO J; 2003 Dec; 22(23):6277-88. PubMed ID: 14633987
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of NF-κB signaling in human dendritic cells by the enteropathogenic Escherichia coli effector protein NleE.
Vossenkämper A; Marchès O; Fairclough PD; Warnes G; Stagg AJ; Lindsay JO; Evans PC; Luong le A; Croft NM; Naik S; Frankel G; MacDonald TT
J Immunol; 2010 Oct; 185(7):4118-27. PubMed ID: 20833837
[TBL] [Abstract][Full Text] [Related]
15. RNF4 negatively regulates NF-κB signaling by down-regulating TAB2.
Tan B; Mu R; Chang Y; Wang YB; Wu M; Tu HQ; Zhang YC; Guo SS; Qin XH; Li T; Li WH; Zhang XM; Li AL; Li HY
FEBS Lett; 2015 Sep; 589(19 Pt B):2850-8. PubMed ID: 26299341
[TBL] [Abstract][Full Text] [Related]
16. TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation.
Shi M; Deng W; Bi E; Mao K; Ji Y; Lin G; Wu X; Tao Z; Li Z; Cai X; Sun S; Xiang C; Sun B
Nat Immunol; 2008 Apr; 9(4):369-77. PubMed ID: 18345001
[TBL] [Abstract][Full Text] [Related]
17. NUMBL interacts with TAB2 and inhibits TNFalpha and IL-1beta-induced NF-kappaB activation.
Ma Q; Zhou L; Shi H; Huo K
Cell Signal; 2008 Jun; 20(6):1044-51. PubMed ID: 18299187
[TBL] [Abstract][Full Text] [Related]
18. The type III secretion effector NleF of enteropathogenic Escherichia coli activates NF-κB early during infection.
Pallett MA; Berger CN; Pearson JS; Hartland EL; Frankel G
Infect Immun; 2014 Nov; 82(11):4878-88. PubMed ID: 25183730
[TBL] [Abstract][Full Text] [Related]
19. Identification of a human NF-kappaB-activating protein, TAB3.
Jin G; Klika A; Callahan M; Faga B; Danzig J; Jiang Z; Li X; Stark GR; Harrington J; Sherf B
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2028-33. PubMed ID: 14766965
[TBL] [Abstract][Full Text] [Related]
20. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN.
Heyninck K; De Valck D; Vanden Berghe W; Van Criekinge W; Contreras R; Fiers W; Haegeman G; Beyaert R
J Cell Biol; 1999 Jun; 145(7):1471-82. PubMed ID: 10385526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
